Delivery Order SPE2DB22D2211-SPE2DB25FSCER
- Not listed
- The Defense Logistics Agency awarded a $2,204.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with...
- This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Cortifoam 10% Aerosol 15GM medical supplies. The contract, valued at $1,065.24, is a firm fixed-price delivery order with a completion date of July 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,259.20, is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies. The contract has a performance period ending on June 11, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.72 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award, valued at $1,140.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, and has a completion date of December 9, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $262 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 15 grams of 10% Cortifoam aerosol. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all work to be completed by August 8, 2023 under the terms of the contract. No subcontractors or set aside designations were indicated. The Defense...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROS 1S medical supplies, with a firm fixed price of $1,120.92 and a completion date of June 30, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide CORTIFOAM 10% AEROSOL 15GM, a specialty pharmaceutical product. The award is a firm fixed price delivery order under an indefinite delivery contract (IDC) valued up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,662 to Amerisourcebergen Drug Corporation for 4562299460 CORTIFOAM 10% AEROSOL 15GM. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the specified pharmaceutical product to the place of performance in Conshohocken, Pennsylvania between September 25-26, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of 4564603968 - CORTIFOAM 10% AEROSOL 15GM, a pharmaceutical product. The contract has a ceiling value of $1,845.39 and an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCERDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,357.98 to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This delivery order represents a firm fixed price transaction with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded and falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor under the DLA Troop Support Medical IDC, the company supplies an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for the topical corticosteroid foam represents a routine fulfillment under the broader pharmaceutical prime vendor arrangement that enables flexible and comprehensive medical supply delivery to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/5/25 |